December 19, 2019 PAIN NEWS NETWORK By Pat Anson, PNN Editor The National Academies of Sciences, Engineering and Medicine (NASEM) is recommending that new clinical guidelines be developed for the treatment of short-term acute pain to reduce the risk of excess opioid prescribing. A 247-page report released by NASEM cites a lack of guidance on…
Tag: FDA
CDC Planning to Update Opioid Guideline in 2021
December 04, 2019 By Pat Anson, PNN Editor The Centers for Disease Control and Prevention is in the initial stages of updating or expanding its controversial opioid prescribing guideline, which has been widely blamed for patient suffering, abandonment and suicide since its release in 2016. CDC officials outlined their plans today at a meeting in…
Use Caution with Implanted Pumps for Intrathecal Administration of Medicines for Pain Management: FDA Safety Communication
The following article was originally posted by the FDA on November 14, 2018 and which was reposted today December 3, 2019. The link to the original article is listed at the bottom of this post. Thank you. Date Issued: November 14, 2018 Audience: Patients who have an implanted pump that delivers medicine into the spinal fluid…
Pain Patient Gives the FDA an Earful
Posted on November 24, 2019 by Dennis J. Capolongo Although not having approval from the FDA, Mr. Gary Snook received a series of Epidural Steroid Injections just like thousands of unsuspecting patients do each year. His fourth injection went terribly wrong condemning Gary to suffer from Adhesive Arachnoiditis, a severe debilitating iatrogenic disease of the…
FDA Cracks Down on CBD Products Making Unproven Pain Therapy Claims
NOVEMBER 21, 2019 The FDA continues its efforts to curb the proliferation of products claiming to contain cannabidiol and marketed as treatments for acute and chronic pain. The agency’s concern has most recently taken the form of a joint warning letter with the Federal Trade Commission to Rooted Apothecary LLC, of Naples, Fla., for illegally…
iCareTalk.net 